Skip to main content

4 Result(s)

within Paul M. O’Byrne Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. No Access

    Chapter

    Future Trends in the Use of Corticosteroids in Asthma

    Corticosteroids have been used to treat a variety of airway diseases since the early 1950s, following an initial study of Carryer et al. [1], who reported the benefits of oral cortisone on ragweed pollen-induc...

    Paul M. O’Byrne in Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends (2000)

  2. No Access

    Article

    The pharmacological modulation of allergen-induced asthma

    Aeroallergens are the most common triggers for the development of asthma. Recent birth cohort studies have identified viral infections occurring against a background of aeroallergen sensitization as a potent r...

    L. L. Ma, Paul M. O’Byrne in Inflammopharmacology (2013)

  3. No Access

    Chapter

    Anti-IgE and Biologic Approaches for the Treatment of Asthma

    Current asthma treatments are effective for the majority of patients with mild-to-moderate disease. However, in those with more severe refractory asthma, agents other than inhaled corticosteroids and beta-agon...

    Patrick D. Mitchell, Amani I. El-Gammal… in Pharmacology and Therapeutics of Asthma an… (2017)

  4. Article

    Open Access

    Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies

    Budesonide-formoterol taken as needed is an emerging treatment for mild asthma.

    J. Mark FitzGerald, Paul M. O’Byrne, Eric D. Bateman, Peter J. Barnes… in Drug Safety (2021)

    Download PDF (1016 KB) View Article